Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1987-2-24
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0003-987X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
123
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
189-91
|
pubmed:dateRevised |
2008-3-17
|
pubmed:meshHeading |
pubmed-meshheading:2949704-Antibodies, Monoclonal,
pubmed-meshheading:2949704-Humans,
pubmed-meshheading:2949704-Interleukin-2,
pubmed-meshheading:2949704-Lymphoma,
pubmed-meshheading:2949704-Receptors, Antigen, T-Cell,
pubmed-meshheading:2949704-Skin Neoplasms,
pubmed-meshheading:2949704-T-Lymphocytes,
pubmed-meshheading:2949704-T-Lymphocytes, Helper-Inducer
|
pubmed:year |
1987
|
pubmed:articleTitle |
New therapies for cutaneous T-cell lymphoma.
|
pubmed:publicationType |
Journal Article
|